
0:00
10:09
Pyridostigmine enhances neuromuscular transmission and is commonly used to treat myasthenia gravis. The effect of pyridostigmine in slowing ALS progression is uncertain. Here we discuss the potential mechanisms, cases, clinical trial data, and potential risks.
Mais episódios de "CReATe Podcast"



Não percas um episódio de “CReATe Podcast” e subscrevê-lo na aplicação GetPodcast.








